News

Why Is ThermoGenesis (THMO) Stock Down 37% Today?

  • ThermoGenesis (NASDAQ: THMO ) stock is taking a beating on Wednesday after the company announced an update on its listing compliance. According to a ThermoGenesis filing, it has received another delisting notice from the Nasdaq Exchange.
    06/12/2024

ThermoGenesis Holdings, Inc. (THMO) Q3 2023 Earnings Call Transcript

  • ThermoGenesis Holdings, Inc. (NASDAQ:THMO ) Q3 2023 Earnings Conference Call November 13, 2023 4:30 PM ET Company Participants Paula Schwartz - Rx Communications, IR Dr. Chris Xu - Chief Executive Officer Jeff Cauble - Chief Financial Officer Conference Call Participants Sean Lee - H.C. Wainwright Operator Good day.
    11/13/2023
Profitability
Dividends
Income Statement
Balance Sheet
Cash Flow Statement
Symbol Frequently Asked Questions

ThermoGenesis Holdings, Inc. (THMO) can buy. Click on Rating Page for detail.

The price of ThermoGenesis Holdings, Inc. (THMO) is 0.17 and it was updated on 2024-07-26 07:00:54.

Currently ThermoGenesis Holdings, Inc. (THMO) is in undervalued.

News
    
News

ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate Update

  • Conference Call to be Held Today at 1:30 p.m. PT/4:30 p.m.
    Mon, Nov. 13, 2023

ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide a Corporate Strategic Update

  • Conference Call to be Held on November 13, 2023 RANCHO CORDOVA, Calif. , Nov. 8, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the third quarter ended September 30, 2023, and provide a corporate strategic update on Thursday, November 13, 2023, after the close of trading.
    Wed, Nov. 08, 2023

ThermoGenesis to Open a New 35,500 Square Foot ReadyStart-IncuStart cGMP Facility in Greater Sacramento

  • An ISO 7 cGMP Cleanroom Facility Grand Opening On October 26, 2023 RANCHO CORDOVA, Calif. , Oct. 26, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing and cell and gene therapy services, announced the grand opening of its new state-of-the-art facility, housing ISO 7 cGMP cleanroom suites, along with research and development labs.
    Thu, Oct. 26, 2023

ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference

  • RANCHO CORDOVA, Calif. , Sept. 6, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that Chris Xu, Ph.D.
    Wed, Sep. 06, 2023

Thermogenesis Holdings, Inc. (THMO) Q2 2023 Earnings Call Transcript

  • Thermogenesis Holdings, Inc. (NASDAQ:THMO ) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Paula Schwartz - IR, Rx Communications Group Chris Xu - CEO Jeff Cauble - CFO Conference Call Participants Sean Lee - H.C. Wainwright & Co. Operator Good day, and welcome to the ThermoGenesis Holdings conference call and webcast to review financial and operating results for the second quarter ended June 30, 2023.
    Fri, Aug. 11, 2023
SEC Filings
SEC Filings
Press Releases
StockPrice Release
More Headlines
News

ThermoGenesis Holdings Announces Second Quarter 2023 Financial Results and Provides Corporate Update

  • Conference Call to be Held Today at 1:30 p.m. PT/4:30 p.m.
  • 08/10/2023

ThermoGenesis Holdings to Announce Financial Results for the Second Quarter ended June 30, 2023 and Provide a Corporate Strategic Update

  • Conference Call to be Held on August 10, 2023 RANCHO CORDOVA, Calif. , Aug. 8, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the second quarter ended June 30, 2023, and provide a corporate strategic update on Thursday, August 10, 2023, after the close of trading.
  • 08/08/2023

ThermoGenesis Expands Board of Directors with the Appointments of Dr. Biao Xi and Dr. James Xu

  • RANCHO CORDOVA, Calif. , July 17, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced the appointments of Biao Xi, Ph.D.
  • 07/17/2023

ThermoGenesis Holdings, Inc. (THMO) Q1 2023 Earnings Call Transcript

  • ThermoGenesis Holdings, Inc. (NASDAQ:THMO ) Q1 2023 Earnings Conference Call May 15, 2023 4:30 PM ET Company Participants Paula Schwartz - Rx Communications Chris Xu - Chief Executive Officer Jeff Cauble - Chief Financial Officer Conference Call Participants Sean Lee - H.C. Wainwright Operator Good day, and welcome to the ThermoGenesis Holdings Conference Call and Webcast to review Financial and Operating Results for the First Quarter ended March 31, 2023.
  • 05/15/2023

Why Is ThermoGenesis (THMO) Stock Up 54% Today?

  • ThermoGenesis (NASDAQ: THMO ) stock is rocketing higher on Thursday after the company announced new cGMP Suites. These cGMP Suites are for early-stage life science and cell gene therapy companies.
  • 03/16/2023

Why ThermoGenesis Stock Is Soaring Wednesday

  • ThermoGenesis said it plans to rent out its current Good Manufacturing Practices suites in the second and third quarters. The company was nearly delisted from the Nasdaq last year.
  • 03/15/2023

THMO Stock Alert: Why ThermoGenesis Is Up 95% Today

  • What's causing ThermoGenesis Holdings (NASDAQ: THMO ) stock traders to suddenly go on a buying binge? Evidently, the share-price rally is prompted by ThermoGenesis's announcement that it's launching a new facility in the Sacramento metro area of California.
  • 03/15/2023

ThermoGenesis Holdings, Inc. (THMO) CEO Dr. Chris Xu on Q3 2022 Results - Earnings Call Transcript

  • ThermoGenesis Holdings, Inc. (NASDAQ:THMO ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Paula Schwartz - Rx Communications Dr. Chris Xu - Chief Executive Officer Jeff Cauble - Chief Financial Officer Conference Call Participants Sean Lee - H.C. Wainwright Operator Good day, and welcome to the ThermoGenesis Holdings Conference Call and Webcast to Review Financial and Operating Results for the Third Quarter Ended September 30, 2022.
  • 11/12/2022

ThermoGenesis Holdings, Inc. (THMO) Reports Q3 Loss, Misses Revenue Estimates

  • ThermoGenesis Holdings, Inc. (THMO) delivered earnings and revenue surprises of -233.33% and 28.79%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
  • 11/10/2022

ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2022 and Provide a Corporate Strategic Update

  • Conference  Call to be Held on November 10, 2022 RANCHO CORDOVA, Calif. , Nov. 7, 2022 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that the Company will release its financial results for the third quarter ended September 30, 2022, and provide a corporate strategic update on Thursday, November 10, 2022.
  • 11/07/2022

ThermoGenesis Holdings, Inc. (THMO) CEO Dr. Chris Xu on Q2 2022 Results - Earnings Call Transcript

  • ThermoGenesis Holdings, Inc. (NASDAQ:THMO ) Q2 2022 Results Conference Call August 11, 2022 3:00 PM ET Company Participants Paula Schwartz - Rx Communications Dr. Chris Xu - Chief Executive Officer Jeff Cauble - Chief Financial Officer Conference Call Participants Sean Lee - H.C. Wainwright Operator Good day, and welcome to the ThermoGenesis Holdings Conference Call and Webcast to Review Financial and Operating Results for the Second Quarter Ended June 30, 2022.
  • 08/13/2022

ThermoGenesis Holdings to Announce Financial Results for the Second Quarter Ended June 30, 2022 and Provide a Corporate Strategic Update

  • Conference  Call to be Held on August 11, 2022 RANCHO CORDOVA, Calif. , Aug. 9, 2022 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the second quarter ended June 30, 2022 and provide a corporate strategic update on Thursday, August 11, 2022.
  • 08/09/2022

Penny Stocks To Buy Now? 4 Stocks To Watch Before August Begins

  • Penny stocks to watch right now The post Penny Stocks To Buy Now? 4 Stocks To Watch Before August Begins appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
  • 07/28/2022

3 Red Hot Penny Stocks Under $1 To Watch Before Next Week

  • There are over 500 Nasdaq & NYSE listed stocks, right, and warrants… The post 3 Red Hot Penny Stocks Under $1 To Watch Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
  • 06/15/2022

ThermoGenesis Holdings, Inc. (THMO) CEO Chris Xu on Q1 2022 Results - Earnings Call Transcript

  • ThermoGenesis Holdings, Inc. (NASDAQ:THMO ) Q1 2022 Earnings Conference Call May 19, 2022 4:30 AM ET Company Participants Paula Schwartz - Rx Communications Chris Xu - Chief Executive Officer Jeff Cauble - Chief Financial Officer Conference Call Participants Operator Good day, and welcome to the ThermoGenesis Holdings Conference Call and Webcast to review Financial and Operating Results for the First Quarter Ended March 31st, 2012. As a reminder, all participants will be in listen-only mode.
  • 05/19/2022

Thermogenesis Holdings, Inc. (THMO) CEO Chris Xu on Q4 2021 Results - Earnings Call Transcript

  • Thermogenesis Holdings, Inc. (THMO) CEO Chris Xu on Q4 2021 Results - Earnings Call Transcript
  • 03/28/2022

Recap: ThermoGenesis Holdings Q3 Earnings

  • ThermoGenesis Holdings (NASDAQ:THMO) reported its Q3 earnings results on Friday, November 12, 2021 at 04:00 PM. Here's what investors need to know about the announcement.
  • 11/15/2021

Thermogenesis Holdings, Inc. (THMO) CEO Jeffery Cauble on Q3 2021 Results - Earnings Call Transcript

  • Thermogenesis Holdings, Inc. (THMO) CEO Jeffery Cauble on Q3 2021 Results - Earnings Call Transcript
  • 11/12/2021

ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2021 and Provide a Corporate Strategic Update

  • RANCHO CORDOVA, Calif., Nov. 5, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the third quarter ended September 30, 2021 and provide a corporate strategic update on Friday, November 12, 2021, after the close of trading.
  • 11/05/2021

ThermoGenesis Awarded NIH SBIR Phase I Grant to Develop Key Cell Processing Disposable for Quintessence Automated manufacturing of Gene-engineered Autologous Cell (GEAC) Therapies

  • RANCHO CORDOVA, Calif., Sept. 14, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company was awarded a $250,000 Phase I Small Business Innovation Research (SBIR) grant to develop and test the single-use sterile cell processing disposable, that will be used by the fully automated Quintessence System.
  • 09/14/2021

New Strong Sell Stocks for August 31st

  • AMWD, CYTK, STIM, OLLI, and THMO have been added to the Zacks Rank #5 (Strong Sell) List on August 31, 2021.
  • 08/31/2021

Thermogenesis Holdings, Inc. (THMO) on Q2 2021 Results - Earnings Call Transcript

  • Thermogenesis Holdings, Inc. (THMO) on Q2 2021 Results - Earnings Call Transcript
  • 08/12/2021

ThermoGenesis Holdings, Inc. (THMO) Reports Q2 Loss, Tops Revenue Estimates

  • ThermoGenesis Holdings, Inc. (THMO) delivered earnings and revenue surprises of -111.11% and 10.60%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
  • 08/12/2021

Recap: ThermoGenesis Holdings Q2 Earnings

  • Shares of ThermoGenesis Holdings (NASDAQ:THMO) decreased 2.7% after the company reported Q2 results. Quarterly Results Earnings per share rose 62.75% over the past year to ($0.38), which missed the estimate of ($0.18).
  • 08/12/2021

ThermoGenesis Holdings, Inc. (THMO) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

  • ThermoGenesis Holdings, Inc. (THMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  • 08/06/2021

ThermoGenesis Holdings to Announce Financial Results for the Second Quarter Ended June 30, 2021 and Provide a Corporate Strategic Update

  • RANCHO CORDOVA, Calif., Aug. 5, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the second quarter ended June 30, 2021 and provide a corporate strategic update on Thursday, August 12, 2021, after the close of trading.
  • 08/05/2021

New Strong Sell Stocks for July 2nd

  • PDCO, SABR, JRSH, UPWK, and THMO have been added to the Zacks Rank #5 (Strong Sell) List on July 2, 2021
  • 07/02/2021

3 Penny Stocks on Reddit Making Big Waves Right Now

  • Which Reddit penny stocks are investors watching right now? Check these 3 out The post 3 Penny Stocks on Reddit Making Big Waves Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
  • 05/24/2021

ThermoGenesis Holdings, Inc. (THMO) CEO Chris Xu on Q1 2021 Results - Earnings Call Transcript

  • ThermoGenesis Holdings, Inc. (THMO) CEO Chris Xu on Q1 2021 Results - Earnings Call Transcript
  • 05/13/2021

Recap: ThermoGenesis Holdings Q1 Earnings

  • Shares of ThermoGenesis Holdings (NASDAQ:THMO) decreased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 85.59% year over year to ($0.16), which missed the estimate of ($0.13).
  • 05/13/2021

3 Short Squeeze Candidates In The Health Care Sector

  • Low float stocks can be some of the most volatile stocks in the market. If you mix in a short squeeze, the potential short-term gains in a low float stock can be extreme.
  • 05/06/2021

ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2021 and Provide a Corporate Strategic Update

  • RANCHO CORDOVA, Calif., May 6, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the first quarter ended March 31, 2021 and provide a corporate strategic update on Thursday, May 13, 2021, after the close of trading.
  • 05/06/2021

ThermoGenesis Holdings, Inc. (THMO) CEO Chris Xu on Q4 2020 Results - Earnings Call Transcript

  • ThermoGenesis Holdings, Inc. (THMO) CEO Chris Xu on Q4 2020 Results - Earnings Call Transcript
  • 03/17/2021

ThermoGenesis Holdings Announces 2020 Year End Financial Results and Provides Corporate Update

  • RANCHO CORDOVA, Calif., March 17, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today reported financial and operating results for the year ended December 31, 2020 and provided a corporate strategic update.
  • 03/17/2021

ThermoGenesis Holdings to Announce Financial Results for the Fourth Quarter Ended December 31, 2020 and Provide a Corporate Strategic Update

  • RANCHO CORDOVA, Calif., March 10, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the fourth quarter ended December 31, 2020 and provide a corporate strategic update on Wednesday, March 17, 2021, after the close of trading.
  • 03/10/2021

ThermoGenesis Holdings, Inc. (THMO) CEO Chris Xu on Q3 2020 Results - Earnings Call Transcript

  • ThermoGenesis Holdings, Inc. (THMO) CEO Chris Xu on Q3 2020 Results - Earnings Call Transcript
  • 11/12/2020
Unlock
THMO Ratings Summary
THMO Quant Ranking